| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Service dEndocrinologie (O.C., J.V.), Chirurgie Générale et Thoracique (P.C.), and Laboratoire de Pathologie Cellulaire (F.L.-M.), Centre Hospitalier Universitaire, 38043 Grenoble, France; INSERM U-329, Hôpital Debrousse (S.P.-D., Y.M.), 69322 Lyon, France; INSERM U-244, Biochimie des Regulations Cellulaires Endocrines, Département de Biologie Moléculaire et Structurale, Commissariat à lEnergie Atomique (P.L., E.C., G.D.), 38054 Grenoble, France
Address all correspondence and requests for reprints to: Dr. Olivier Chabre, Service dEndocrinologie, Centre Hospitalier Universitaire, 38043 Grenoble, France. E-mail: olivier.chabre{at}ujf-grenoble.fr
We present an in vivo and in vitro study
of congenital adrenal hyperplasia in a patient with 11ß-hydroxylase
deficiency. Sequencing of the CYP11B1 gene showed two
new base substitutions, a conservative 954 G
C transversion at the
last base of exon 5 (T318T), and a IVS8 + 4A
G transition in intron
8. In addition, two polymorphisms were found in exons 1 and 2. The
genetically female patient was raised as a male because of severe
pseudohermaphroditism. Glucocorticoid-suppressive treatment encountered
difficulties in equilibration and compliance, resulting in uncontrolled
hypertension with pronounced hypertrophic cardiomyopathy. At 42 yr of
age the occurrence of central retinal vein occlusion with permanent
loss of left eye vision led to the decision to perform bilateral
laparoscopic adrenalectomy. Surgery was followed by normalization of
blood pressure and good compliance with glucocorticoid and androgen
substitutive therapies. In vitro, adrenal cells in
culture and isolated mitochondria showed extremely low
11ß-hydroxylase activity. Analysis of adrenal CYP11B1
messenger ribonucleic acid (mRNA) by RT-PCR and sequencing showed the
expression of a shorter mRNA that lacked exon 8 and did not contain
either the exon 5 mutation or the exon 1 and 2 polymorphisms. This
suggested that one CYP11B1 allele carried the intron 8
mutation, responsible for skipping exon 8. The other allele carried the
exon 5 mutation, and its mRNA was not detectable. Western blot analysis
showed weak expression of a shorter CYP11B immunoreactive band of 43
kDa, consistent with truncation of exon 8. Thus, bilateral
adrenalectomy in this patient allowed effective treatment of severe
hypertension and helped in understanding the mechanisms and
physiopathological consequences of two novel mutations of
CYP11B1.
This article has been cited by other articles:
![]() |
J. J. Van Wyk and E. M. Ritzen The Role of Bilateral Adrenalectomy in the Treatment of Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2993 - 2998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Portrat, P. Mulatero, K. M. Curnow, J.-L. Chaussain, Y. Morel, and L. Pascoe Deletion Hybrid Genes, due to Unequal Crossing Over between CYP11B1 (11{beta}-Hydroxylase) and CYP11B2(Aldosterone Synthase) Cause Steroid 11{beta}-Hydroxylase Deficiency and Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3197 - 3201. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |